Debt-to-equity of Oncology Institute, Inc. from 30 Sep 2020 to 30 Sep 2025

Taxonomy & unit
ratio: %
Description
Debt-to-equity (D/E) ratio is used to evaluate a company's financial leverage and is calculated by dividing a company's total liabilities by its shareholder equity.
Summary
Oncology Institute, Inc. quarterly Debt-to-equity in % history and change rate from 30 Sep 2020 to 30 Sep 2025.
  • Oncology Institute, Inc. Debt-to-equity for the quarter ending 30 Sep 2025 was -5339%, a 1313% decline year-over-year.
Debt-to-equity, Quarterly (%)
Debt-to-equity, YoY Quarterly Change (%)

Oncology Institute, Inc. Quarterly Debt-to-equity (%)

Period Value YoY Chg Change % Date
Q3 2025 -5339% -5779% -1313% 30 Sep 2025
Q2 2025 4359% +4051% +1319% 30 Jun 2025
Q1 2025 1204% +966% +405% 31 Mar 2025
Q4 2024 722% +536% +288% 31 Dec 2024
Q3 2024 440% +290% +194% 30 Sep 2024
Q2 2024 307% +175% +132% 30 Jun 2024
Q1 2024 238% +133% +127% 31 Mar 2024
Q4 2023 186% +100% +117% 31 Dec 2023
Q3 2023 150% +69% +85% 30 Sep 2023
Q2 2023 133% +68% +104% 30 Jun 2023
Q1 2023 105% +38% +56% 31 Mar 2023
Q4 2022 86% +18% +26% 31 Dec 2022
Q3 2022 81% +19% +31% 30 Sep 2022
Q2 2022 65% -36% -36% 30 Jun 2022
Q1 2022 67% -223% -77% 31 Mar 2022
Q4 2021 68% +411% 31 Dec 2021
Q3 2021 62% +478% 30 Sep 2021
Q2 2021 101% 30 Jun 2021
Q1 2021 290% 31 Mar 2021
Q4 2020 -343% 31 Dec 2020
Q3 2020 -416% 30 Sep 2020
* An asterisk sign (*) next to the value indicates that the value is likely invalid.